{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T01:26:27Z","timestamp":1769563587525,"version":"3.49.0"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,6,2]]},"DOI":"10.7759\/cureus.15389","type":"journal-article","created":{"date-parts":[[2021,6,2]],"date-time":"2021-06-02T13:59:22Z","timestamp":1622642362000},"source":"Crossref","is-referenced-by-count":5,"title":["Isolated Double-Positive Optic Neuritis: A Case of Aquaporin-4 and Myelin Oligodendrocyte Glycoprotein Antibody Seropositivity"],"prefix":"10.7759","author":[{"given":"Matthew C","family":"Mason","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dario A","family":"Marotta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hassan","family":"Kesserwani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1001\/archophthalmol.2007.26","article-title":"Clinical course of optic neuritis in patients with relapsing neuromyelitis optica","volume":"126","author":"Papais-Alvarenga RM","year":"2008","unstructured":"Papais-Alvarenga RM, Carellos SC, Alvarenga MP, Holander C, Bichara RP, Thuler LC. Clinical course of optic neuritis in patients with relapsing neuromyelitis optica. Arch Ophthalmol. 2008, 126:12-16. 10.1001\/archophthalmol.2007.26","journal-title":"Arch Ophthalmol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1097\/wno.0000000000000700","article-title":"Acute management of optic neuritis: an evolving paradigm","volume":"38","author":"Horton L","year":"2018","unstructured":"Horton L, Bennett JL. Acute management of optic neuritis: an evolving paradigm. J Neuroophthalmol. 2018, 38:358-367. 10.1097\/wno.0000000000000700","journal-title":"J Neuroophthalmol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1177\/1352458519845112","article-title":"The clinical spectrum and incidence of anti-MOG-associated acquired demyelinating syndromes in children and adults","volume":"26","author":"de Mol CL","year":"2020","unstructured":"de Mol CL, Wong Y, van Pelt ED, et al.. The clinical spectrum and incidence of anti-MOG-associated acquired demyelinating syndromes in children and adults. Mult Scler. 2020, 26:806-814. 10.1177\/1352458519845112","journal-title":"Mult Scler"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1177\/1352458517735191","article-title":"Epidemiology of NMOSD in catalonia: influence of the new 2015 criteria in incidence and prevalence estimates","volume":"24","author":"Sep\u00falveda M","year":"2018","unstructured":"Sep\u00falveda M, Aldea M, Escudero D, et al.. Epidemiology of NMOSD in catalonia: influence of the new 2015 criteria in incidence and prevalence estimates. Mult Scler. 2018, 24:1843-1851. 10.1177\/1352458517735191","journal-title":"Mult Scler"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2018.00217","article-title":"MOG-IgG-associated optic neuritis, encephalitis, and myelitis: lessons learned from neuromyelitis optica spectrum disorder","volume":"9","author":"dos Passos GR","year":"2018","unstructured":"dos Passos GR, Oliveira LM, da Costa BK, Apostolos-Pereira SL, Callegaro D, Fujihara K, Sato DK. MOG-IgG-associated optic neuritis, encephalitis, and myelitis: lessons learned from neuromyelitis optica spectrum disorder. Front Neurol. 2018, 9:217. 10.3389\/fneur.2018.00217","journal-title":"Front Neurol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1212\/wnl.0000000000000101","article-title":"Distinction between MOG antibody-positive and AQP4 antibody-positive NMO spectrum disorders","volume":"82","author":"Sato DK","year":"2014","unstructured":"Sato DK, Callegaro D, Lana-Peixoto MA, et al.. Distinction between MOG antibody-positive and AQP4 antibody-positive NMO spectrum disorders. Neurology. 2014, 82:474-481. 10.1212\/wnl.0000000000000101","journal-title":"Neurology"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2018.4053","article-title":"Clinical, radiologic, and prognostic features of myelitis associated with myelin oligodendrocyte glycoprotein autoantibody","volume":"76","author":"Dubey D","year":"2019","unstructured":"Dubey D, Pittock SJ, Krecke KN, et al.. Clinical, radiologic, and prognostic features of myelitis associated with myelin oligodendrocyte glycoprotein autoantibody. JAMA Neurol. 2019, 76:301. 10.1001\/jamaneurol.2018.4053","journal-title":"JAMA Neurol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0079083","article-title":"An optimized immunohistochemistry technique improves NMO-IgG detection: study comparison with cell-based assays","volume":"8","author":"H\u00f6ftberger R","year":"2013","unstructured":"H\u00f6ftberger R, Sabater L, Marignier R, et al.. An optimized immunohistochemistry technique improves NMO-IgG detection: study comparison with cell-based assays. PLoS One. 2013, 8:e79083. 10.1371\/journal.pone.0079083","journal-title":"PLoS One"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-018-1144-2","article-title":"MOG encephalomyelitis: international recommendations on diagnosis and antibody testing","volume":"15","author":"Jarius S","year":"2018","unstructured":"Jarius S, Paul F, Aktas O, et al.. MOG encephalomyelitis: international recommendations on diagnosis and antibody testing. J Neuroinflammation. 2018, 15:134. 10.1186\/s12974-018-1144-2","journal-title":"J Neuroinflammation"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2019.04.042","article-title":"Epidemiologic and clinical characteristics of optic neuritis in japan","volume":"126","author":"Ishikawa H","year":"2019","unstructured":"Ishikawa H, Kezuka T, Shikishima K, et al.. Epidemiologic and clinical characteristics of optic neuritis in japan. Ophthalmology. 2019, 126:1385-1398. 10.1016\/j.ophtha.2019.04.042","journal-title":"Ophthalmology"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2013.08.034","article-title":"Glycine receptor and myelin oligodendrocyte glycoprotein antibodies in Turkish patients with neuromyelitis optica","volume":"335","author":"Woodhall M","year":"2013","unstructured":"Woodhall M, Coban A, Waters P, et al.. Glycine receptor and myelin oligodendrocyte glycoprotein antibodies in Turkish patients with neuromyelitis optica. J Neurol Sci. 2013, 335:221-223. 10.1016\/j.jns.2013.08.034","journal-title":"J Neurol Sci"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3109\/01658107.2015.1072726","article-title":"Clinical profile of anti-myelin oligodendrocyte glycoprotein antibody seropositive cases of optic neuritis","volume":"39","author":"Matsuda R","year":"2015","unstructured":"Matsuda R, Kezuka T, Umazume A, Okunuki Y, Goto H, Tanaka K. Clinical profile of anti-myelin oligodendrocyte glycoprotein antibody seropositive cases of optic neuritis. Neuroophthalmology. 2015, 39:213-219. 10.3109\/01658107.2015.1072726","journal-title":"Neuroophthalmology"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1212\/wnl.0000000000001729","article-title":"International consensus diagnostic criteria for neuromyelitis optica spectrum disorders","volume":"85","author":"Wingerchuk DM","year":"2015","unstructured":"Wingerchuk DM, Banwell B, Bennett JL, et al.. International consensus diagnostic criteria for neuromyelitis optica spectrum disorders. Neurology. 2015, 85:177-189. 10.1212\/wnl.0000000000001729","journal-title":"Neurology"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1177\/1756286420945135","article-title":"Recent developments in MOG-IgG associated neurological disorders","volume":"13","author":"Hegen H","year":"2020","unstructured":"Hegen H, Reindl M. Recent developments in MOG-IgG associated neurological disorders. Ther Adv Neurol Disord. 2020, 13: 10.1177\/1756286420945135","journal-title":"Ther Adv Neurol Disord"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1056\/nejm199202273260901","article-title":"A randomized, controlled trial of corticosteroids in the treatment of acute optic neuritis","volume":"326","author":"Beck RW","year":"1992","unstructured":"Beck RW, Cleary PA, Anderson MM, et al.. A randomized, controlled trial of corticosteroids in the treatment of acute optic neuritis. N Engl J Med. 1992, 326:581-588. 10.1056\/nejm199202273260901","journal-title":"N Engl J Med"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1177\/1352458506071174","article-title":"Therapeutic efficacy of plasma exchange in NMO-IgG-positive patients with neuromyelitis optica","volume":"13","author":"Watanabe S","year":"2007","unstructured":"Watanabe S, Nakashima I, Misu T, Miyazawa I, Shiga Y, Fujihara K, Itoyama Y. Therapeutic efficacy of plasma exchange in NMO-IgG-positive patients with neuromyelitis optica. Mult Scler. 2007, 13:128-132. 10.1177\/1352458506071174","journal-title":"Mult Scler"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000009758","article-title":"Steroid-sparing maintenance immunotherapy for MOG-IgG associated disorder","volume":"95","author":"Chen JJ","year":"2020","unstructured":"Chen JJ, Flanagan EP, Bhatti MT, et al.. Steroid-sparing maintenance immunotherapy for MOG-IgG associated disorder. Neurology. 2020, 95:111-120. 10.1212\/WNL.0000000000009758","journal-title":"Neurology"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/60298-isolated-double-positive-optic-neuritis-a-case-of-aquaporin-4-and-myelin-oligodendrocyte-glycoprotein-antibody-seropositivity","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:34:54Z","timestamp":1707507294000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/60298-isolated-double-positive-optic-neuritis-a-case-of-aquaporin-4-and-myelin-oligodendrocyte-glycoprotein-antibody-seropositivity"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,2]]},"references-count":17,"URL":"https:\/\/doi.org\/10.7759\/cureus.15389","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6,2]]}}}